Limin Group announces third product price increase amid market recovery signs for Abamectin and Emamectin benzoate

On March 28, 2025, Limin Group issued a product price adjustment notice, announcing an immediate 5% increase in the prices of Mancozeb, Abamectin, and Emamectin benzoate technicals and related formulations. This marks the third price adjustment for these products by Limin, following previous adjustments on September 2, 2024, and October 8, 2024.

Market Demand Drives Price Increase Amid Rising Costs

In the price adjustment notice, Limin stated that recent changes in the market environment have led to increased demand for certain products and a rise in the prices of various raw materials, resulting in higher production costs for the company. In order to ensure the stable quality of products and maintain supply capabilities, the company has decided to implement this price increase. Limin Group is committed to providing high-quality products and services to its partners and will maintain full and effective communication with them through its marketing personnel.

Product Prices and Volumes Rise, Signaling Market Recovery

In 2025, the raw materials of Abamectin and Emamectin benzoate have shown a positive trend of rising prices and volumes. Currently, the market production rate for Abamectin products is relatively low, with tight spot availability. The price of Emamectin benzoate technical has also increased in sync. The domestic market has been activated, and exports of high-purity products have increased. Compared to the bottom prices in early 2024, the prices of these two products have risen by more than 40%. This trend not only highlights the inherent product advantages of Abamectin and Emamectin benzoate but also reflects the recovery of the pesticide market, with core products in certain niche areas leading the industry's rebound after the downturn in the past two years.

Increasing Market Demand and Advantages in Pest Resistance Management

Since 2024, the global inventory digestion of Emamectin benzoate and Abamectin has been satisfactory, with the overseas market's "de-stocking" process essentially completed. As the pesticide application season approaches, international order volumes and exports have shown a steady upward trend.

Compared to traditional insecticides, Abamectin and Emamectin benzoate have excellent compatibility. Chlorantraniliprole, when combined with Abamectin and Emamectin benzoate, forms a perfect combination in terms of both performance and cost. They complement each other, enhancing efficacy and delaying the development of pest resistance. Against the backdrop of increasing demand for pest resistance management in crops, the product advantages of Abamectin and Emamectin benzoate have become even more prominent, which is also one of the key reasons for their sustained price increases.

Click to read or download the "2025 China Pesticide Industry Watch" 

Join us at the 2025 China Pesticide Exporting Workshop to gain in-depth insights into the dynamics of the pesticide supply chain, and explore innovative solutions and opportunities for collaboration.

  Contact Person  

Mickey Shan | AGROPAGES

Email: mickey@agropages.com; agropages@vip.163.com

Tel/WhatsApp/Wechat:+86 18705817985